David J. Cutter

The National Non-Hodgkin Lymphoma Audit: Insights and Impact.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 20, 2025

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.

Journal: BMJ (Clinical research ed.)

Published: August 27, 2025

Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.

Journal: Blood advances

Published: August 01, 2025

Causes of excess nonlymphoma death in 58 000 patients with DLBCL diagnosed during 1997 to 2020 and followed for up to 25 years.

Journal: Blood advances

Published: August 01, 2025

Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 11, 2025

Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship.

Journal: Seminars in radiation oncology

Published: December 13, 2024

Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 02, 2024

Perfect is the enemy of good: Reply to Struikmans et al.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: September 27, 2024

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.

Journal: British journal of haematology

Published: August 23, 2024

Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.

Journal: British journal of haematology

Published: August 08, 2024

Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

The National Non-Hodgkin Lymphoma Audit: Insights and Impact.

The National Non-Hodgkin Lymphoma Audit: Insights and Impact.

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.

Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.

Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.

Causes of excess nonlymphoma death in 58 000 patients with DLBCL diagnosed during 1997 to 2020 and followed for up to 25 years.

Causes of excess nonlymphoma death in 58 000 patients with DLBCL diagnosed during 1997 to 2020 and followed for up to 25 years.

Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000.

Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000.

Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship.

Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship.

Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.

Proton beam therapy for mediastinal Hodgkin lymphoma: A prospective study of clinical efficacy and safety.

Perfect is the enemy of good: Reply to Struikmans et al.

Perfect is the enemy of good: Reply to Struikmans et al.

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.

Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.

Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.

Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.

Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives.

Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives.

Authors' reply to Oke and Welch.

Authors' reply to Oke and Welch.